Hypogonadism and CHARGE association

Patricia G. Wheeler, Charmian A. Quigley, Ab Sadeghi-Nejad, David Weaver

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The G of the CHARGE association represents genital hypoplasia, which is typically recognized only in males (micropenis/cryptorchidism). The cause of genital hypoplasia in this disorder has not been determined. We now report the cases of nine individuals with CHARGE association and hypogonadotropic hypogonadism, manifested by hypogenitalism and gonadotropins at or below minimal detectable levels at ages when these hormones should be readily measurable. We suggest that central hypogonadism is responsible not only for the genital hypoplasia in male patients but also for the lack of secondary sexual development in patients of both sexes. Since hypogonadotropic hypogonadism appears to be the usual cause of genital and pubertal abnormalities in CHARGE association, measurement of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) concentrations in infants up to 2-3 months of age who are suspected of having this disorder could help establish the diagnosis. Determination of serum LH and FSH concentrations in teenagers with CHARGE association could result in early diagnosis of hypogonadotropic hypogonadism, allowing for treatment of hormonal deficiencies and minimization of potential secondary psychosocial and medical problems. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)228-231
Number of pages4
JournalAmerican Journal of Medical Genetics
Volume94
Issue number3
DOIs
StatePublished - Sep 18 2000

Fingerprint

CHARGE Syndrome
Hypogonadism
Follicle Stimulating Hormone
Luteinizing Hormone
Sexual Development
Cryptorchidism
Serum
Gonadotropins
Early Diagnosis
Hormones

Keywords

  • Follicle-stimulating hormone
  • Genital hypoplasia
  • Hypogonadotropic hypogonadism
  • Luteinizing hormone

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Hypogonadism and CHARGE association. / Wheeler, Patricia G.; Quigley, Charmian A.; Sadeghi-Nejad, Ab; Weaver, David.

In: American Journal of Medical Genetics, Vol. 94, No. 3, 18.09.2000, p. 228-231.

Research output: Contribution to journalArticle

Wheeler, Patricia G. ; Quigley, Charmian A. ; Sadeghi-Nejad, Ab ; Weaver, David. / Hypogonadism and CHARGE association. In: American Journal of Medical Genetics. 2000 ; Vol. 94, No. 3. pp. 228-231.
@article{3bb24461155046a99afdc6384d659cfc,
title = "Hypogonadism and CHARGE association",
abstract = "The G of the CHARGE association represents genital hypoplasia, which is typically recognized only in males (micropenis/cryptorchidism). The cause of genital hypoplasia in this disorder has not been determined. We now report the cases of nine individuals with CHARGE association and hypogonadotropic hypogonadism, manifested by hypogenitalism and gonadotropins at or below minimal detectable levels at ages when these hormones should be readily measurable. We suggest that central hypogonadism is responsible not only for the genital hypoplasia in male patients but also for the lack of secondary sexual development in patients of both sexes. Since hypogonadotropic hypogonadism appears to be the usual cause of genital and pubertal abnormalities in CHARGE association, measurement of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) concentrations in infants up to 2-3 months of age who are suspected of having this disorder could help establish the diagnosis. Determination of serum LH and FSH concentrations in teenagers with CHARGE association could result in early diagnosis of hypogonadotropic hypogonadism, allowing for treatment of hormonal deficiencies and minimization of potential secondary psychosocial and medical problems. (C) 2000 Wiley-Liss, Inc.",
keywords = "Follicle-stimulating hormone, Genital hypoplasia, Hypogonadotropic hypogonadism, Luteinizing hormone",
author = "Wheeler, {Patricia G.} and Quigley, {Charmian A.} and Ab Sadeghi-Nejad and David Weaver",
year = "2000",
month = "9",
day = "18",
doi = "10.1002/1096-8628(20000918)94:3<228::AID-AJMG8>3.0.CO;2-H",
language = "English",
volume = "94",
pages = "228--231",
journal = "American Journal of Medical Genetics, Part C: Seminars in Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Hypogonadism and CHARGE association

AU - Wheeler, Patricia G.

AU - Quigley, Charmian A.

AU - Sadeghi-Nejad, Ab

AU - Weaver, David

PY - 2000/9/18

Y1 - 2000/9/18

N2 - The G of the CHARGE association represents genital hypoplasia, which is typically recognized only in males (micropenis/cryptorchidism). The cause of genital hypoplasia in this disorder has not been determined. We now report the cases of nine individuals with CHARGE association and hypogonadotropic hypogonadism, manifested by hypogenitalism and gonadotropins at or below minimal detectable levels at ages when these hormones should be readily measurable. We suggest that central hypogonadism is responsible not only for the genital hypoplasia in male patients but also for the lack of secondary sexual development in patients of both sexes. Since hypogonadotropic hypogonadism appears to be the usual cause of genital and pubertal abnormalities in CHARGE association, measurement of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) concentrations in infants up to 2-3 months of age who are suspected of having this disorder could help establish the diagnosis. Determination of serum LH and FSH concentrations in teenagers with CHARGE association could result in early diagnosis of hypogonadotropic hypogonadism, allowing for treatment of hormonal deficiencies and minimization of potential secondary psychosocial and medical problems. (C) 2000 Wiley-Liss, Inc.

AB - The G of the CHARGE association represents genital hypoplasia, which is typically recognized only in males (micropenis/cryptorchidism). The cause of genital hypoplasia in this disorder has not been determined. We now report the cases of nine individuals with CHARGE association and hypogonadotropic hypogonadism, manifested by hypogenitalism and gonadotropins at or below minimal detectable levels at ages when these hormones should be readily measurable. We suggest that central hypogonadism is responsible not only for the genital hypoplasia in male patients but also for the lack of secondary sexual development in patients of both sexes. Since hypogonadotropic hypogonadism appears to be the usual cause of genital and pubertal abnormalities in CHARGE association, measurement of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) concentrations in infants up to 2-3 months of age who are suspected of having this disorder could help establish the diagnosis. Determination of serum LH and FSH concentrations in teenagers with CHARGE association could result in early diagnosis of hypogonadotropic hypogonadism, allowing for treatment of hormonal deficiencies and minimization of potential secondary psychosocial and medical problems. (C) 2000 Wiley-Liss, Inc.

KW - Follicle-stimulating hormone

KW - Genital hypoplasia

KW - Hypogonadotropic hypogonadism

KW - Luteinizing hormone

UR - http://www.scopus.com/inward/record.url?scp=0034684030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034684030&partnerID=8YFLogxK

U2 - 10.1002/1096-8628(20000918)94:3<228::AID-AJMG8>3.0.CO;2-H

DO - 10.1002/1096-8628(20000918)94:3<228::AID-AJMG8>3.0.CO;2-H

M3 - Article

C2 - 10995509

AN - SCOPUS:0034684030

VL - 94

SP - 228

EP - 231

JO - American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

JF - American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

SN - 1552-4825

IS - 3

ER -